NeedleSpotter Inc.
Terms of Use
Together4Cancer® Beacon™
Effective August 17, 2026 Last updated August 17, 2026
These Terms of Use are divided into two sections. Please read the section that applies to you.
- Section A — Patients and caregivers together4cancer.com and Before Treatment Starts™
- Section B — Healthcare professionals Together4Cancer® Compass newsletter at together4cancer.org
For all questions: contact@together4cancer.com
Section A
Patients and caregivers
together4cancer.com · navigator.together4cancer.com · Before Treatment Starts™
These Terms of Use (“Terms”) govern your access to and use of Together4Cancer® Beacon™, including navigator.together4cancer.com, together4cancer.com, Before Treatment Starts™, and related patient- and caregiver-facing features, tools, content, and services operated by NeedleSpotter Inc. (collectively, “Beacon” or the “Service”).
By purchasing, accessing, or using Beacon, you agree to these Terms and to our Privacy Policy.
If you do not agree to these Terms, do not use Beacon.
Questions may be sent to contact@together4cancer.com.
01 About Beacon
Together4Cancer® Beacon™ is an educational cancer navigation and decision-support platform operated by NeedleSpotter Inc.
Beacon is designed to help people affected by cancer and their caregivers organize information, identify issues that may be relevant to upcoming healthcare decisions, understand questions worth discussing, and prepare for conversations with their healthcare team.
Depending on the features available to you, Beacon may allow you to:
- provide information about a cancer diagnosis, treatment, symptoms, preferences, concerns, or care situation;
- upload medical reports, clinical notes, test results, or other documents;
- ask questions about information relevant to cancer care;
- organize information into a decision map or similar navigation framework;
- identify questions or topics that may warrant discussion with your healthcare team;
- generate educational summaries, question lists, care-team briefs, readiness records, or other documents; and
- preserve or use certain information from previous interactions where continuity features are available.
Beacon may add, remove, modify, or rename features over time.
Beacon is intended to support, not replace, conversations between patients, caregivers, and qualified healthcare professionals.
02 Beacon does not provide medical care
NeedleSpotter Inc. is not acting as your doctor, oncologist, nurse, pharmacist, therapist, medical practice, hospital, or other healthcare provider through Beacon.
Beacon does not:
- diagnose cancer or any other medical condition;
- determine whether you have a particular disease or complication;
- prescribe medications;
- order laboratory tests, imaging, procedures, or treatments;
- determine which treatment you should receive;
- establish a physician-patient or other clinical relationship;
- independently verify the accuracy of your medical record;
- continuously monitor your condition;
- provide emergency medical services; or
- replace evaluation, advice, treatment, or professional judgment from a qualified healthcare professional.
Information provided through Beacon is educational and informational in nature.
Beacon may identify considerations, questions, treatment categories, tests, biomarkers, evidence, guidelines, areas of uncertainty, clinical trials, or other healthcare information that may be useful to discuss with your healthcare team.
The appearance of any treatment, test, biomarker, clinical trial, guideline, or other option in Beacon does not mean that it is appropriate, indicated, available, safe, or recommended for you.
Similarly, the absence of an option or question from Beacon does not mean that it is unnecessary or irrelevant.
Decisions about your healthcare should be made with appropriately qualified healthcare professionals who know your individual medical circumstances.
No professional or clinical duty of care is created between you and NeedleSpotter Inc. through your use of Beacon.
03 Not for emergencies or urgent medical assessment
If you believe you may be experiencing a medical emergency, severe or rapidly worsening symptoms, or another situation requiring prompt medical assessment, contact 911 or your local emergency service, your oncology team, or another qualified healthcare professional.
Beacon is not an emergency service and is not designed to determine whether you require urgent or emergency medical attention.
Do not use Beacon to decide whether symptoms are serious enough to require immediate care.
Do not delay obtaining medical care because of information provided — or not provided — by Beacon.
Beacon conversations are not continuously monitored by medical professionals or NeedleSpotter Inc. personnel.
04 Artificial intelligence and automated content
Beacon uses artificial intelligence and other software technologies to process information and generate personalized educational content.
Artificial intelligence has important limitations.
You understand and acknowledge that Beacon outputs may:
- contain factual errors or omissions;
- misunderstand information you provide;
- incorrectly interpret or summarize a medical document;
- fail to identify information that is clinically important;
- identify information as relevant when it is not relevant to you;
- reflect incomplete, conflicting, or outdated information;
- fail to account for individual clinical circumstances;
- prioritize information differently from your healthcare professional;
- misinterpret ambiguous terminology or medical abbreviations; or
- present information confidently even when the information is uncertain or incorrect.
Beacon may use published medical literature, clinical guidelines, regulatory information, public databases, and other knowledge sources to support its responses.
Medical evidence, regulatory approvals, clinical guidelines, and standards of care change over time. Beacon cannot guarantee that every response reflects the most current, complete, or applicable information available.
NeedleSpotter Inc. does not manually or clinically review every Beacon conversation or output.
You should review medically significant information with an appropriate healthcare professional before making, delaying, stopping, or changing a healthcare decision.
A healthcare professional may reasonably disagree with information generated by Beacon.
05 Your information affects Beacon’s outputs
Beacon’s responses depend substantially on the information available to it.
You are responsible for providing information that is accurate and complete to the best of your knowledge and for correcting or updating information when your situation changes.
Beacon may generate incomplete, inaccurate, or inappropriate information if, for example:
- a pathology report, imaging result, biomarker result, genomic result, medication list, diagnosis, stage, or treatment history is missing;
- a medical document is incomplete, unclear, outdated, or difficult to interpret;
- information you enter is inaccurate;
- your diagnosis or treatment plan has changed;
- relevant medical information has not yet been entered or uploaded; or
- your healthcare team has information that Beacon does not have.
Beacon does not independently obtain or verify your complete medical record unless a particular feature expressly states otherwise.
Do not interpret Beacon’s failure to identify an issue, question, test, treatment, or consideration as confirmation that it is medically unnecessary.
06 Eligibility and use on behalf of another person
You must be at least 18 years old to independently create an account, purchase access, or use Beacon.
An adult may use Beacon in connection with the care of another person, including a family member or minor, where the adult has the legal authority, authorization, or appropriate permission to provide the information involved.
If you upload, enter, or otherwise provide information relating to another person, you represent that you have the right or appropriate authorization to provide that information for the purpose for which you are using Beacon.
You should not upload another person’s medical records or personal information merely because you possess a copy of them.
07 Your account and access
Your Beacon access is personal to you unless otherwise stated.
You are responsible for maintaining the confidentiality of your account credentials, authentication links, passwords, and other access information.
You may not knowingly allow another person to access Beacon using your credentials except where that person is appropriately assisting you with your care.
If you believe your account or access link has been compromised, contact us at contact@together4cancer.com.
Individual consumer access may not be used to provide Beacon services to multiple unrelated patients or clients.
08 User content and medical-record uploads
“User Content” means information you provide through Beacon, including questions, text, medical information, reports, documents, images, feedback, and other materials.
You retain whatever ownership rights you have in your User Content.
By providing User Content, you authorize NeedleSpotter Inc. and the service providers necessary to operate Beacon to process that content as necessary to provide the Service and as described in our Privacy Policy.
You represent that:
- you have the right to provide the User Content;
- providing the User Content does not violate another person’s legal rights;
- you have obtained any authorization or permission required to provide information about another person; and
- you will not knowingly provide unlawful, fraudulent, malicious, or materially false content.
Beacon is not your physician’s or hospital’s official medical-record system. Uploading information to Beacon does not place that information into your healthcare provider’s medical record and does not mean your healthcare team has received or reviewed it.
If information is important to your care, communicate it directly to your healthcare team through the channels they provide.
09 Conversation history, context, memory, and record retention
Beacon may provide features that retain, retrieve, summarize, or use information from previous interactions to make later interactions more useful.
These features are provided for convenience.
Beacon is not a permanent medical-record system or guaranteed conversation archive.
Conversation history, downloaded chats, saved context, generated documents, and other records are not necessarily the same thing.
For example, Beacon may retain certain contextual information to support continuity without retaining or displaying a complete verbatim history of every prior conversation.
The availability and duration of conversation history, saved context, generated documents, and other information may vary by product, version, access method, or feature and may change over time.
You are responsible for downloading or otherwise saving any conversation, document, summary, or other Beacon output that you want to retain permanently.
Do not rely on Beacon as the sole repository for:
- medical records;
- appointment instructions;
- treatment information;
- medication information;
- clinical results;
- questions you need to remember; or
- information needed for future medical care.
Additional details regarding retention and deletion of personal information are provided in our Privacy Policy.
10 Privacy and health information
Your use of Beacon is governed by our Privacy Policy, available at together4cancer.com/privacy, which is incorporated into these Terms by reference.
To operate Beacon, NeedleSpotter Inc. may use third-party service providers for functions such as:
- cloud hosting and infrastructure;
- artificial-intelligence processing;
- database and data storage;
- platform security;
- authentication;
- payment processing;
- email and service communications;
- analytics; and
- advertising measurement.
The categories of service providers we use, information they may process, retention practices, and your privacy choices are described more fully in our Privacy Policy.
No internet-based service can guarantee absolute security. We use safeguards intended to protect information consistent with the nature of the information and the Service, but cannot guarantee that unauthorized access, disclosure, loss, or misuse will never occur.
Nothing in these Terms limits any privacy or data-protection right that cannot legally be waived.
11 Advertising and measurement partners
NeedleSpotter Inc. may use advertising and measurement technologies provided by companies such as Meta Platforms, Inc. and Google LLC on certain public-facing Together4Cancer or Beacon marketing pages.
These technologies help us understand whether advertising is effective and how people discover Beacon.
Depending on the technology used, your settings, and applicable law, advertising or measurement providers may receive limited information such as:
- that a public-facing webpage was viewed;
- that an advertisement was clicked;
- advertising campaign or referral information;
- that a visitor reached a particular marketing, checkout, or conversion step;
- that a purchase or other designated conversion event occurred;
- date and time information;
- browser, device, and operating-system information;
- IP address or similar technical information;
- cookies, advertising identifiers, or similar identifiers; and
- where configured and permitted, hashed or otherwise protected identifiers used for advertising attribution or measurement.
What we do not intentionally provide to advertising partners
We do not intentionally provide Meta, Google, or other advertising platforms with the substance of your personalized use of Beacon for advertising purposes, including:
- the content of your Beacon conversations;
- medical records or documents you upload;
- information extracted from your medical records;
- your cancer diagnosis or stage;
- pathology, imaging, biomarker, genomic, or laboratory results;
- medications or treatment history;
- symptoms or side effects you describe;
- questions you ask Beacon;
- personalized Decision Readiness Records, Care Team Briefs, decision maps, or similar Beacon outputs; or
- other detailed clinical information you provide while using Beacon.
We do not intentionally use the content of your medical records or personalized Beacon conversations to create advertising audiences or personalize advertisements.
Our Privacy Policy provides additional information about advertising technologies, cookies, measurement providers, and available privacy choices.
12 Individual and institutional use
Unless otherwise stated when access is provided, consumer Beacon access is for individual, personal use.
You may use Beacon for yourself or, where appropriately authorized, while assisting someone whose care you support.
You may not use an individual consumer license to operate or support:
- a professional patient-navigation service;
- a health coaching or consulting program;
- a healthcare practice;
- an institutional patient-support program;
- a commercial service;
- a research program;
- a support group serving multiple patients; or
- another organization-wide or multi-patient service.
Hospitals, healthcare organizations, nonprofits, employers, patient-support organizations, research organizations, and other institutions may use Beacon only through access authorized by NeedleSpotter Inc. or under a separate agreement.
Institutional versions of Beacon may operate differently from consumer versions, including with respect to authentication, data retention, session history, integrations, and available features.
Additional terms may apply to institutional access.
For institutional licensing, contact contact@together4cancer.com.
13 Access period, fees, and billing
The price, access period, payment structure, and features included with a Beacon product are those displayed when you purchase or receive access.
Unless the checkout page expressly states that a product automatically renews, purchasing a fixed-term Beacon access pass does not create an automatically renewing subscription.
If a Beacon product is offered as a recurring subscription, the recurring price, billing period, renewal terms, and cancellation process will be disclosed before purchase.
Payments may be processed through a third-party payment processor.
We may change prices or offerings for future purchases. A change in price will not retroactively change the price of an access period you have already purchased.
14 Refunds
The refund policy applicable to your purchase is the policy displayed on the relevant product or checkout page at the time of purchase.
Please review that policy before completing your transaction.
To request a refund where permitted, contact contact@together4cancer.com and include the email address associated with your purchase.
Nothing in these Terms limits any refund, cancellation, cooling-off, or other consumer-protection right that cannot legally be waived.
15 Generated documents and your right to share them
Beacon may generate documents or outputs including:
- Decision Readiness Records™;
- Pre-Treatment Care Team Briefs™;
- question lists;
- decision maps;
- educational summaries; and
- other personalized materials.
You may use documents generated specifically for you, or for a person whose care you are authorized to support, for personal healthcare purposes.
You may share these materials with people involved in your care, including:
- physicians and other healthcare professionals;
- hospitals and healthcare organizations;
- caregivers and family members;
- patient navigators or advocates;
- professionals assisting with financial, logistical, or supportive-care issues; and
- healthcare professionals or institutions from whom you are seeking another opinion.
Beacon documents are intended to facilitate conversations. They are not medical records prepared or certified by a healthcare professional and should not be represented as such.
You may not:
- resell Beacon outputs;
- systematically generate Beacon outputs for unrelated third parties;
- reproduce Beacon materials as part of a competing product;
- use Beacon outputs to train or build a competing system;
- remove branding for purposes of representing Beacon content as your own commercial product; or
- incorporate Beacon into a commercial service without written authorization from NeedleSpotter Inc.
16 Acceptable use
You agree not to:
- share account credentials or secure access links in a manner that permits unauthorized use;
- access another person’s Beacon account without authorization;
- use bots, scripts, scraping tools, automated agents, or similar technologies to systematically extract Beacon content;
- reverse engineer or attempt to reconstruct Beacon’s proprietary prompts, workflows, navigation architecture, decision frameworks, software, or underlying systems;
- circumvent technical, access, payment, usage, or security restrictions;
- interfere with the security or operation of Beacon;
- introduce malware, malicious code, or other harmful material;
- upload content that you do not have the right to provide;
- intentionally provide fabricated clinical information for deceptive, fraudulent, or harmful purposes;
- use Beacon to impersonate a healthcare professional or falsely represent Beacon outputs as professional medical advice;
- resell or commercially exploit Beacon without authorization;
- use Beacon to develop, benchmark, train, or improve a directly competing commercial product through systematic extraction of Beacon outputs; or
- use Beacon in violation of applicable law.
We may restrict or terminate access where reasonably necessary to protect users, NeedleSpotter Inc., third parties, or the integrity and security of the Service.
17 Intellectual property
Beacon and its underlying software, design, interfaces, navigation architecture, workflows, frameworks, methods, prompts, branding, document structures, and original content are owned by or licensed to NeedleSpotter Inc. and are protected by applicable intellectual-property laws.
Together4Cancer®, Beacon™, Before Treatment Starts™, Decision Readiness Record™, Pre-Treatment Care Team Brief™, and other names, marks, methods, frameworks, and branding used by NeedleSpotter Inc. remain the intellectual property of NeedleSpotter Inc. or their respective owners.
Your right to use personalized Beacon outputs for your healthcare purposes does not transfer ownership of Beacon’s underlying technology, proprietary methods, prompts, frameworks, or intellectual property to you.
Nothing in these Terms restricts your ability to independently use your own medical information.
If you voluntarily provide suggestions or general product feedback, NeedleSpotter Inc. may use that feedback to improve Beacon without obligation to you. Personal information or health information contained in feedback remains subject to our Privacy Policy.
18 Third-party information, resources, and services
Beacon may reference, summarize, or link to information provided by third parties, including:
- healthcare organizations;
- medical publications;
- clinical guidelines;
- regulatory authorities;
- clinical-trial registries;
- government databases;
- professional societies;
- advocacy organizations; and
- other websites, tools, products, or services.
NeedleSpotter Inc. does not control all third-party information or services and does not guarantee their accuracy, completeness, availability, security, or suitability.
A reference or link does not necessarily constitute an endorsement.
Third-party information may change without notice.
Your interactions with third-party websites and services are governed by the terms and policies applicable to those services.
19 Service communications
We may send you communications reasonably necessary to operate Beacon, such as:
- account or authentication messages;
- purchase confirmations;
- access information;
- security notifications;
- service changes;
- billing notices; or
- important changes to these Terms or our Privacy Policy.
Transactional or service communications are separate from marketing communications.
Where applicable law requires separate consent for promotional email, text messaging, or other marketing communications, we will request that consent separately.
20 Service availability and changes
Beacon relies on software systems, internet connectivity, artificial-intelligence services, hosting providers, databases, and other third-party technologies.
Service interruptions, delays, errors, data-processing failures, or outages may occur.
We do not guarantee uninterrupted or error-free availability.
NeedleSpotter Inc. may modify, replace, add, suspend, or discontinue particular features where reasonably necessary for:
- product development;
- security;
- safety;
- legal or regulatory compliance;
- changes in third-party technology;
- technical maintenance; or
- operational reasons.
We are not responsible for delays or failures resulting from circumstances beyond our reasonable control, including failures of internet services, cloud providers, artificial-intelligence providers, payment processors, cyber incidents, natural disasters, governmental actions, or other events beyond our reasonable control.
You should not rely on Beacon as the only means of storing or accessing information necessary for your medical care.
21 Disclaimer of warranties
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, BEACON AND ALL RELATED SERVICES, INFORMATION, CONTENT, AND OUTPUTS ARE PROVIDED “AS IS” AND “AS AVAILABLE.”
NeedleSpotter Inc. disclaims warranties, express or implied, including warranties of merchantability, fitness for a particular purpose, accuracy, non-infringement, and uninterrupted availability to the extent those warranties may legally be disclaimed.
We do not warrant that:
- Beacon will identify every issue relevant to your healthcare;
- any Beacon output will be complete, current, or error-free;
- information generated by Beacon will apply to your particular medical circumstances;
- Beacon will correctly interpret every medical document;
- your healthcare professional will agree with or act upon information generated by Beacon;
- any third-party information identified by Beacon will remain available;
- Beacon will operate without interruption or loss of information; or
- use of Beacon will produce any particular medical, financial, emotional, logistical, or other outcome.
Some jurisdictions do not permit certain warranty exclusions. In those jurisdictions, these exclusions apply only to the extent permitted by law.
22 Limitation of liability
To the fullest extent permitted by applicable law, NeedleSpotter Inc. and its officers, directors, employees, contractors, affiliates, and service providers will not be liable for indirect, incidental, special, exemplary, consequential, or punitive damages arising from or relating to Beacon, these Terms, or your use of the Service.
This includes damages arising from:
- reliance on AI-generated or other Beacon content;
- inaccurate, incomplete, misunderstood, outdated, or omitted information;
- decisions made after using Beacon;
- failure to obtain or delay in obtaining medical advice or care;
- inability to access Beacon;
- inability to access previous conversation history;
- loss of saved context, data, documents, or generated outputs;
- unauthorized account access despite reasonable safeguards;
- service interruptions or failures; or
- third-party information, websites, products, or services.
To the fullest extent permitted by law, NeedleSpotter Inc.’s aggregate liability arising from your use of a paid consumer Beacon product will not exceed the amount you paid NeedleSpotter Inc. for the Beacon product giving rise to the claim during the twelve months preceding the event giving rise to the claim.
Nothing in these Terms excludes or limits liability that cannot lawfully be excluded or limited.
23 Indemnification for misuse
To the extent permitted by applicable law, you agree to indemnify and hold NeedleSpotter Inc. and its officers, directors, employees, and affiliates harmless from third-party claims, damages, liabilities, and reasonable costs arising directly from:
- your unlawful use of Beacon;
- User Content you provide without the legal right or authorization to do so;
- your commercial exploitation of Beacon in violation of these Terms;
- your violation of another person’s privacy or intellectual-property rights; or
- your material violation of these Terms.
This provision does not require you to indemnify NeedleSpotter Inc. for claims arising from NeedleSpotter Inc.’s own conduct where liability cannot lawfully be shifted to you.
24 Suspension and termination
NeedleSpotter Inc. may suspend or terminate your access to Beacon if you:
- materially violate these Terms;
- misuse the Service;
- attempt to compromise Beacon’s security;
- engage in fraudulent activity;
- attempt unauthorized commercial use or systematic extraction;
- threaten the security or integrity of the Service; or
- use Beacon in a manner that creates material risk to NeedleSpotter Inc., users, or third parties.
We may also suspend access where required by law.
Any refund following termination will be determined according to the refund policy applicable to your purchase and applicable law.
Termination does not affect provisions that by their nature should survive termination, including provisions concerning intellectual property, disclaimers, limitations of liability, indemnification, and dispute resolution.
25 Geographic availability
Beacon may be accessible from locations outside the jurisdiction in which NeedleSpotter Inc. operates.
We do not represent that every feature, information source, healthcare reference, or service is appropriate or legally available in every jurisdiction.
Medical practices, treatment availability, drug approvals, clinical guidelines, healthcare systems, and legal requirements differ by location.
Information generated by Beacon should therefore be discussed with healthcare professionals familiar with the healthcare system and requirements applicable to you.
26 Governing law and disputes
These Terms are governed by the laws of the State of New Jersey, United States, without regard to conflict-of-laws principles.
Except where applicable law provides otherwise, any legal proceeding arising from these Terms or your use of Beacon will be brought in a state or federal court having jurisdiction in New Jersey, and you consent to the jurisdiction of those courts.
Nothing in this section limits any consumer-protection right, remedy, or jurisdictional protection that cannot legally be waived.
27 Changes to these Terms
We may revise these Terms as Beacon, our business, technology, or applicable requirements change.
The current version will display its Last Updated date.
If we make a material change that significantly affects your rights or obligations, we may provide additional notice through Beacon, by email, or through another reasonable method.
Your continued use of Beacon after updated Terms become effective constitutes acceptance of the updated Terms to the extent permitted by applicable law.
28 Entire agreement and severability
These Terms, together with our Privacy Policy and any additional terms presented for a particular Beacon product, purchase, or institutional program, constitute the agreement governing your use of that Service.
If any provision of these Terms is determined to be invalid or unenforceable, that provision will be enforced to the maximum extent permitted by law, and the remaining provisions will remain in effect.
Our failure to enforce a provision of these Terms on one occasion does not waive our right to enforce it later.
You may not transfer or assign your rights under these Terms without our consent.
NeedleSpotter Inc. may assign these Terms in connection with a merger, acquisition, reorganization, sale of assets, or similar corporate transaction, subject to applicable law.
29 Contact
Together4Cancer® Beacon™ is operated by NeedleSpotter Inc.
For questions about Beacon or these Terms: contact@together4cancer.com
Section B
Healthcare professionals
together4cancer.org · Together4Cancer® Compass newsletter
These Terms govern your access to and use of together4cancer.org and the Together4Cancer® Compass newsletter, operated by NeedleSpotter Inc. By subscribing to or accessing Compass content, you agree to be bound by these Terms.
This section is also relevant to pharmaceutical companies and healthcare organizations considering commercial arrangements with NeedleSpotter Inc. in connection with Compass.
B1 About Together4Cancer® Compass
The Together4Cancer® Compass is a clinician-facing oncology newsletter published by NeedleSpotter Inc. Compass delivers clinical decision gap content, patient communication tools, and actionable oncology guidance to community oncologists, nurse practitioners, and other healthcare professionals.
NeedleSpotter Inc. also operates NeedleSpotter, a B2B oncology marketing agency that partners with pharmaceutical companies on HCP-targeted educational programs. Compass is one channel through which these programs are delivered. Commercial arrangements are structured to maintain editorial independence of non-promotional content, as described in Section B4 below.
Compass content is for educational purposes only. It does not constitute clinical guidance, treatment recommendations, or medical advice. All clinical decisions remain the responsibility of the individual clinician and their patient.
B2 Subscription and access
Compass is a free newsletter delivered by email. By subscribing to Compass — including by not opting out of a subscription invitation — you acknowledge that:
- You are a licensed healthcare professional or work in a clinical or administrative capacity in a healthcare setting;
- You consent to receive Compass issues at your professional email address;
- You have read and agree to these Terms and the Compass Privacy Policy at together4cancer.com/privacy;
- You understand that Compass may deliver both non-promotional educational content and clearly marked promotional communications on behalf of pharmaceutical company partners.
You may unsubscribe from Compass at any time by clicking the unsubscribe link in any issue or by emailing contact@together4cancer.com.
B3 Content — non-promotional and promotional
Non-promotional content
The majority of Compass content is non-promotional editorial content produced independently by NeedleSpotter Inc., including clinical decision gap analyses, patient communication scripts, disease state updates, and clinical tool recommendations. Non-promotional content may be supported by unrestricted educational grants from pharmaceutical companies. Sponsors of non-promotional content do not participate in its creation, review, or approval.
Promotional content
Compass may deliver MLR-reviewed promotional email communications on behalf of pharmaceutical company partners. All promotional communications will be:
- Clearly marked as PROMOTIONAL at the top of the email;
- Identified by the name of the sponsoring pharmaceutical company;
- Compliant with applicable FDA promotional guidelines and PhRMA codes of conduct.
Promotional communications are delivered as separate, clearly marked emails. Subscribers may opt out of promotional communications while remaining subscribed to non-promotional Compass content by emailing contact@together4cancer.com with the subject line “Opt out of promotional emails.”
B4 Editorial independence and sponsored content disclosure
NeedleSpotter Inc. maintains full editorial independence over all non-promotional Compass content. Commercial arrangements of any kind — including unrestricted educational grants, NPI-matched reporting, sponsored tracking, MLR-reviewed promotional programs, sponsored content series, disease awareness campaigns, patient education initiatives, branded and unbranded HCP communications, and any other pharmaceutical or healthcare industry partnership — do not influence the editorial content, clinical positions, or therapy references in non-promotional Compass issues. Sponsors do not review, approve, or modify non-promotional editorial content prior to publication.
All sponsored, promotional, or commercially supported content will be explicitly identified at the point of delivery. Identification will include one or more of the following disclosures as appropriate to the content type:
- “Promotional” — for MLR-reviewed branded promotional communications;
- “Sponsored by [Company Name]” — for branded sponsored content series or disease awareness campaigns;
- “Supported by an unrestricted educational grant from [Company Name]” — for grant-funded non-promotional content;
- “This communication includes reach measurement tools provided by an educational grant supporter” — for issues containing sponsor tracking tags or pixels;
- Any other disclosure required by applicable FDA guidelines, PhRMA codes of conduct, or industry standards.
NeedleSpotter Inc. reserves the right to enter into any lawful pharmaceutical or healthcare industry commercial arrangement in connection with Compass, provided that non-promotional editorial independence is maintained and all commercial relationships are disclosed to subscribers at the point of delivery.
This editorial independence policy is a condition of all commercial arrangements entered into by NeedleSpotter Inc. in connection with Compass.
B5 Editorial independence
NeedleSpotter Inc. maintains full editorial independence over all non-promotional Compass content. Commercial arrangements of any kind do not influence the editorial content, clinical positions, or therapy references in non-promotional Compass issues. Sponsors do not review, approve, or modify non-promotional editorial content prior to publication. This editorial independence is a condition of all commercial arrangements entered into by NeedleSpotter Inc. in connection with Compass.
B6 Pharmaceutical company partners — specific acknowledgments
If you are accessing these Terms on behalf of a pharmaceutical company or healthcare organization considering a commercial arrangement with NeedleSpotter Inc. in connection with Compass, you acknowledge that:
- NPI-matched engagement reporting does not involve the transfer of subscriber personal information to the partner;
- Sponsored tracking tags collect engagement metrics only and are disclosed to subscribers;
- MLR-reviewed promotional communications are delivered as clearly marked separate communications in compliance with applicable FDA and PhRMA guidelines;
- Unrestricted educational grant arrangements require full editorial independence as a condition of the arrangement;
- All commercial arrangements are governed by a separate written agreement between NeedleSpotter Inc. and the partner organization.
To discuss commercial arrangements: contact@together4cancer.com
B7 Intellectual property
All Compass content — including clinical analyses, patient communication scripts, decision gap frameworks, and editorial content — is the proprietary intellectual property of NeedleSpotter Inc. and is protected by copyright law.
You may share individual Compass issues with colleagues for personal educational purposes. You may not:
- Reproduce, republish, or distribute Compass content in any commercial context without our prior written consent;
- Incorporate Compass content into any product, service, training program, or commercial offering without a license agreement;
- Remove or obscure any attribution, copyright notice, or branding from Compass content.
To inquire about licensing Compass content for institutional or commercial use, contact contact@together4cancer.com.
B8 Disclaimers
Compass content is produced to high clinical standards and is grounded in published medical literature and clinical guidelines. However, NeedleSpotter Inc. makes no warranty regarding the completeness, accuracy, or applicability of Compass content to any specific clinical situation. Compass content reflects the state of published evidence at the time of publication and may not reflect subsequent developments. NeedleSpotter Inc. is not responsible for clinical decisions made in reliance on Compass content.
B9 Limitation of liability
To the fullest extent permitted by applicable law, NeedleSpotter Inc. shall not be liable for any indirect, incidental, special, consequential, or punitive damages arising from your use of or reliance on Compass content, including any clinical decisions made in connection with that content.
B10 Governing law
These Terms are governed by the laws of the State of New Jersey, United States. Any disputes shall be resolved in the courts of New Jersey.
B11 Changes to these Terms
When we make material changes to Section B — particularly changes affecting commercial arrangements or subscriber data practices — we will notify subscribers by email before those changes take effect.





